You just know that Lilly’s new Type 2 diabetes drug Tirzepatide will be offered up to Type 1s. How lucky are we! Another exorbitantly priced diabetes drug! Just what the diabetes community needed. ¯_(ツ)_/¯. Tirzepatide's Retail Price Set at About $12,666 Per Year

And it will be decided we cant live without it.


I’ve got to say that Ozempic has been a game-changer for my T1 care. In my 32 years of dealing with T1, I rank it up there with innovations like Humalog, OmniPod and Dexcom. (Lyumjev, you are a disappointment.)

Even though it’s been out for a while and turned into a T2 blockbuster, I don’t see Novo trying to seek approval for T1s for Ozempic. My guess is that Lilly will make enough money off of T2s with Mounjaro as well.

1 Like